L Catterton to make nearly 10x on Zarbee’s Naturals sale


Johnson & Johnson, Zarbee's, Zak Zarbock, healthcare, pediatrics, private equity, L Catterton, merger, M&A
Photo of Zarbee's cough medicine sourced from company website
L Catterton, the consumer-focused PE firm, will make roughly 10x its money with the sale of Zarbee’s Naturals, a source said. Johnson & Johnson Consumer Inc said July 30 that it agreed to buy Zarbee’s, which makes “family-safe” health and ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.